A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12–24 Months. - Langley, Joanne M; Nolan, Terry M; Rämet, Mika; Richmond, Peter C; Filho, Nelson Rosário; Haazen, Wouter; Berg, Sara P H van den; Williams, Kristi; Bastian, Arangassery Rosemary; Omoruyi, Edmund; Durkin, Joanna Williams; Salisch, Nadine; et al. (Open Forum Infectious Diseases, 2024)